Exposure to low energy amplitude modulated radiofrequency electromagnetic fields (EMF) is associated with rapid improvement in quality of life (QoL) status in patients with advanced hepatocellular carcinoma (HCC), using various EORTC-C30 analyses.
ESMO Congress 2019
Electromagnetic fields and optomechanics in cancer diagnostics and treatment
Frontiers In Bioscience (Landmark edition) 23 (2018): 1391-1406
PDF . Site
Response to Alternating Electric Fields of Tubulin Dimers and Microtubule Ensembles in Electrolytic Solutions
Scientific Reports nº 1 (2017): 9594
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies
Chinese Journal of Cancer (2013) Vol. 32 Issue 11
Treating cancer with amplitude-modulated electromagnetic fields: a potential paradigm shift, again?
British Journal of Cancer (2012) 106
Cancer cell proliferation is inhibited by specific modulation frequencies
Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields
British Journal of Cancer (2011) 105
Cancer as a dynamical phase transition
Theoretical Biology and Medical Modelling nº 1 (2011): 30
Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach
Journal of Experimental & Clinical Cancer Research
Molecular dynamics simulations of tubulin structure and calculations of electrostatic properties of microtubules
Mathematical and Computer Modelling nº 10 (2005): 1055-1070
The anti-proliferative effects of amplitude-modulated RF EMF (AM RF EMF) at tumor-specific frequencies on glioblastoma cells
Wake Forest School of Medicine
The anti-proliferative effects of RF EMF amplitude-modulated at tumor-specific frequencies are mediated by calcium
Evaluation of the safety standards and the potential efficacy of tumor exposure with the Therabionic device
Want to know more?
Send us your e-mail. We will keep you updated about our innovative treatment.
Email Address *
This new medical device has not yet received regulatory approval and is not available for commercial distribution.
New Hampshire, USA
35 Main Street, Suite 208
+1 603 310-5044
São Paulo, Brasil
Rua Barata Ribeiro, 398 cj.22
São Paulo, SP
+55 11 2389-8577